Clinical Trials List
2008-10-31 - 2012-10-31
Phase III
Terminated6
ICD-10D38.2
Neoplasm of uncertain behavior of pleura
ICD-10D38.3
Neoplasm of uncertain behavior of mediastinum
ICD-10D38.4
Neoplasm of uncertain behavior of thymus
ICD-9235.8
Neoplasm of uncertain behavior of pleura, thymus and mediastinum
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chun-Ru Chien Division of Radiation Therapy
- Chih-Yen Tu Division of Thoracic Medicine
- Wei-Chun Chen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chao-Hua Chiu Division of Thoracic Medicine
- 賴信良 Division of Thoracic Medicine
- Yuh-Min Chen Division of Thoracic Medicine
- Yi-Wei Chen Division of Hematology & Oncology
- 蔡俊明 Division of Thoracic Medicine
- 李毓芹 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 陳焜結 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chih-Hung Chen Division of Thoracic Medicine
- Chun-Hua Wang Division of Thoracic Medicine
- 曾雁明 Division of Radiation Therapy
- 柯皓文 Division of Thoracic Medicine
- 陳豪成 Division of Thoracic Medicine
- Chih-Teng Yu Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chong-Jen Yu Division of Thoracic Medicine
- 陳冠宇 Division of Thoracic Medicine
- JIN-YUAN SHIH Division of Thoracic Medicine
- 許峰銘 Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- 林宗哲 Division of Thoracic Medicine
- James Chih-Hsin Yang Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 胡渝昌 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
600 participants
